VX-702

· Vertex Pharmaceuticals Incorporated

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for VX-702, covering 2007-12-07 to 2007-12-07. Get the full timeline:

Most recent: Clinical Trial Update: Phase 2 Clinical Study in Rheumatoid Arthritis With an Investigational Oral p38 MAP Kinase Inhibitor VX-702 [Phase 2]

See pricing